Ticker

No recent analyst price targets found for SYRA.

Latest News for SYRA

Syra Health Delivers its First Profitable Quarter in Q1 2026, Expands Margins and Strengthens Financial Position

Syra Health delivered its first-ever profitable quarter in Q1 2026, with net income of approximately $241,000, representing a substantial 151% increase over the year-ago period Q1 2026 EPS grew to $0.02 per share versus ($0.04) in Q1 2025 Gross Margin rose to 42.7%, up 11 percentage points year-over-year Total revenue increased to $2.3 million, up 22% when compared to the prior year period CARMEL, Ind., May 7, 2026…

PRNewsWire • May 7, 2026
Syra Health To Announce First Quarter 2026 Financial Results

CARMEL, Ind., April 30, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA), ("Syra Health" or the "Company"), an integrated healthcare solutions company powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today that it will report financial results for its first quarter ended on March 31, 2026, on Thursday, May 7, 2026.

PRNewsWire • Apr 30, 2026
Syra Health (NASDAQ:SYRA) Trading 4.4% Higher – Should You Buy?

Syra Health Corp. (NASDAQ: SYRA - Get Free Report)'s stock price traded up 4.4% during trading on Thursday. The stock traded as high as $0.44 and last traded at $0.4261. 37,035 shares changed hands during mid-day trading, a decline of 34% from the average session volume of 56,540 shares. The stock had previously closed at

Defense World • Apr 24, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for SYRA.

No House trades found for SYRA.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top